Results 291 to 300 of about 47,543 (305)
Some of the next articles are maybe not open access.

Concurrent chemoradiotherapy in non-small cell lung cancer

2004
In a previous meta-analysis of adjuvant chemotherapy in NSCLC there was a 13% reduction in the risk of death in patients receiving radical radiotherapy. This overview specifically excluded trials in which chemotherapy and radiotherapy were given concurrently (NSCLCCG 1995).
N P, Rowell, N P, O'rourke
openaire   +2 more sources

Concurrent chemoradiotherapy for unresectable thymic carcinoma.

Chang Gung medical journal, 2005
Thymic carcinoma is a rare anterior mediastinal neoplasm. It is more invasive and has a poorer prognosis than ordinary thymoma. Complete curative resection is frequently impossible to achieve because of extensive invasion or metastasis at diagnosis. The role of systemic chemotherapy and the optimal regimen in thymic carcinoma remain uncertain.
Yen-Yang, Chen   +3 more
openaire   +1 more source

Concurrent chemoradiotherapy is not the only answer

Clinical Otolaryngology, 2007
D G, Grant, M A, Birchall
openaire   +2 more sources

Patient and Treatment Factors in Concurrent Chemoradiotherapy

2016
The MACH-NC analysis demonstrated a 6.5 % absolute improvement in 5-year overall survival with concurrent chemoradiotherapy (CCRT) over radiotherapy (RT) alone. High-dose cisplatin (100 mg/m2 on days 1, 22, and 43 during RT) was identified as the most effective regimen.
openaire   +1 more source

P28.04 Pneumonitis With Durvalumab Following Concurrent Chemoradiotherapy

Journal of Thoracic Oncology, 2021
W. Hanayneh   +6 more
openaire   +1 more source

[Concurrent chemoradiotherapy update].

Bulletin du cancer, 1999
F, Reboul   +5 more
openaire   +1 more source

Concurrent Chemoradiotherapy Tolerated in Recurrent HNSCC

MD Conference Express, 2014
E. H. Nichols, M. Yao
openaire   +1 more source

[Head and neck: concurrent chemoradiotherapy].

Gan to kagaku ryoho. Cancer & chemotherapy, 2007
Yuichiro, Higaki, Yoshinobu, Tomita
openaire   +1 more source

Home - About - Disclaimer - Privacy